<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01293149</url>
  </required_header>
  <id_info>
    <org_study_id>IRB11-00075</org_study_id>
    <nct_id>NCT01293149</nct_id>
  </id_info>
  <brief_title>Clonidine in Femoral Nerve Block Surgery in Children</brief_title>
  <official_title>The Effects of Clonidine on Postoperative Analgesia After Single Shot Femoral Nerve Block Following Arthroscopic Knee Surgery in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nationwide Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nationwide Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Knee arthroscopy is a common surgical procedure in pediatrics in which the knee joint is
      visualized through a small camera to help diagnose and treat knee problems. This procedure is
      commonly accomplished with the use of general anesthesia. Regional anesthesia is commonly
      completed with a single injection of local anesthetic around the femoral nerve to provide
      pain relief for several hours following knee arthroscopy. The intent of this study is to
      examine the effects of clonidine in addition to local anesthetics for femoral nerve blockade
      in providing children and adolescents post-operative analgesia. The investigators hypothesize
      the addition of low dose clonidine (1 mcg/kg) provides an additional 4 hours of post
      operative analgesia following arthroscopic knee surgery and reduces post-operative opiate
      requirement.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>24 hours</time_frame>
    <description>The primary end-point of the study is time from performance of femoral nerve block to onset of pain in the distribution of the femoral nerve.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>15, 30 &amp; 60 mins. post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>15, 30 &amp; 60 mins. post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen saturation</measure>
    <time_frame>15, 30 &amp; 60 mins. post-op</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Other Reconstructive Surgery</condition>
  <arm_group>
    <arm_group_label>Ropivacaine plus clonidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ropivacaine plus clonidine for femoral block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ropivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ropivacaine alone for femoral block</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>ropivacaine 0.2% 0.5 ml/kg (max 20 ml)</description>
    <arm_group_label>Ropivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clonidine</intervention_name>
    <description>clonidine 1 mcg/kg AND ropivacaine 0.2% 0.5 ml/kg (max 20 ml)</description>
    <arm_group_label>Ropivacaine plus clonidine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologist (ASA) functional status I or II

          -  Patients scheduled for arthroscopic knee surgery only

        Exclusion Criteria:

          -  Patients with history of chronic opioid therapy, central or peripheral neuropathy,
             contraindications to regional anesthesia, history of allergy to clonidine or
             ropivicaine, or anterior cruciate ligament reconstructive surgery in addition to knee
             arthroscopy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amod Sawardekar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nationwide Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2011</study_first_submitted>
  <study_first_submitted_qc>February 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2011</study_first_posted>
  <last_update_submitted>May 6, 2015</last_update_submitted>
  <last_update_submitted_qc>May 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 8, 2015</last_update_posted>
  <responsible_party>
    <name_title>Amod Sawardekar, MD/ Clinical Assistant Professor</name_title>
    <organization>Nationwide Children's Hospital</organization>
  </responsible_party>
  <keyword>knee, reconstructive surgery</keyword>
  <keyword>femoral nerve block</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Clonidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

